-transparent.png){kind=logo}
This pilot study involved six men with major depression treated with nefazodone dosed either twice/day or once/day at bedtime. Depression was rated before nefazodone therapy and at 4 weeks by the self-report version of the Hamilton Depression Rating Scale. A simple 10-cm visual analog side effect scale for daytime drowsiness was completed at the latter time. Dosages of nefazodone were at least 400 mg/day. The results suggest that nefazodone given once/day at bedtime may be as effective as the currently accepted twice/day regimen, with less daytime drowsiness.
Related Publications
J C Voris, and
G N Shaurette, and
P S Sebastian, and
L A Will-Wallace
January 1977,
Journal of clinical pharmacology,
J C Voris, and
G N Shaurette, and
P S Sebastian, and
L A Will-Wallace
January 1995,
Lijecnicki vjesnik,
J C Voris, and
G N Shaurette, and
P S Sebastian, and
L A Will-Wallace
January 1982,
Clinical therapeutics,
J C Voris, and
G N Shaurette, and
P S Sebastian, and
L A Will-Wallace
April 2004,
Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
J C Voris, and
G N Shaurette, and
P S Sebastian, and
L A Will-Wallace
January 1975,
Proceedings of the Australian Association of Neurologists,
J C Voris, and
G N Shaurette, and
P S Sebastian, and
L A Will-Wallace
January 1991,
Pharmacotherapy,
J C Voris, and
G N Shaurette, and
P S Sebastian, and
L A Will-Wallace
October 1996,
Pediatrics,
J C Voris, and
G N Shaurette, and
P S Sebastian, and
L A Will-Wallace
November 2008,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J C Voris, and
G N Shaurette, and
P S Sebastian, and
L A Will-Wallace
November 1980,
The Medical journal of Australia,
J C Voris, and
G N Shaurette, and
P S Sebastian, and
L A Will-Wallace
August 2019,
Nigerian journal of clinical practice,
